U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C28H33ClN2
Molecular Weight 433.028
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BUCLIZINE

SMILES

CC(C)(C)C1=CC=C(CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(Cl)C=C4)C=C1

InChI

InChIKey=MOYGZHXDRJNJEP-UHFFFAOYSA-N
InChI=1S/C28H33ClN2/c1-28(2,3)25-13-9-22(10-14-25)21-30-17-19-31(20-18-30)27(23-7-5-4-6-8-23)24-11-15-26(29)16-12-24/h4-16,27H,17-21H2,1-3H3

HIDE SMILES / InChI
Molecular Formula C28H33ClN2
Molecular Weight 433.028
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:32:42 UTC 2023
Edited
by admin
on Fri Dec 15 16:32:42 UTC 2023
Record UNII
0C94V6X681
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BUCLIZINE
INN   MI   VANDF   WHO-DD  
INN  
Official Name English
buclizine [INN]
Common Name English
BUCLIZINE [MI]
Common Name English
1-(P-TERT-BUTYLBENZYL)-4-(P-CHLORO-.ALPHA.-PHENYLBENZYL)PIPERAZINE
Common Name English
BUCLIZINE [VANDF]
Common Name English
Buclizine [WHO-DD]
Common Name English
Classification Tree Code System Code
WHO-ATC R06AE01
Created by admin on Fri Dec 15 16:32:42 UTC 2023 , Edited by admin on Fri Dec 15 16:32:42 UTC 2023
WHO-VATC QR06AE01
Created by admin on Fri Dec 15 16:32:42 UTC 2023 , Edited by admin on Fri Dec 15 16:32:42 UTC 2023
WHO-ATC R06AE51
Created by admin on Fri Dec 15 16:32:42 UTC 2023 , Edited by admin on Fri Dec 15 16:32:42 UTC 2023
NCI_THESAURUS C29578
Created by admin on Fri Dec 15 16:32:42 UTC 2023 , Edited by admin on Fri Dec 15 16:32:42 UTC 2023
WHO-VATC QR06AE51
Created by admin on Fri Dec 15 16:32:42 UTC 2023 , Edited by admin on Fri Dec 15 16:32:42 UTC 2023
Code System Code Type Description
ECHA (EC/EINECS)
201-448-1
Created by admin on Fri Dec 15 16:32:42 UTC 2023 , Edited by admin on Fri Dec 15 16:32:42 UTC 2023
PRIMARY
MESH
C046894
Created by admin on Fri Dec 15 16:32:42 UTC 2023 , Edited by admin on Fri Dec 15 16:32:42 UTC 2023
PRIMARY
ChEMBL
CHEMBL1201271
Created by admin on Fri Dec 15 16:32:42 UTC 2023 , Edited by admin on Fri Dec 15 16:32:42 UTC 2023
PRIMARY
EVMPD
SUB05947MIG
Created by admin on Fri Dec 15 16:32:42 UTC 2023 , Edited by admin on Fri Dec 15 16:32:42 UTC 2023
PRIMARY
SMS_ID
100000085865
Created by admin on Fri Dec 15 16:32:42 UTC 2023 , Edited by admin on Fri Dec 15 16:32:42 UTC 2023
PRIMARY
RXCUI
59636
Created by admin on Fri Dec 15 16:32:42 UTC 2023 , Edited by admin on Fri Dec 15 16:32:42 UTC 2023
PRIMARY RxNorm
DRUG BANK
DB00354
Created by admin on Fri Dec 15 16:32:42 UTC 2023 , Edited by admin on Fri Dec 15 16:32:42 UTC 2023
PRIMARY
INN
291
Created by admin on Fri Dec 15 16:32:42 UTC 2023 , Edited by admin on Fri Dec 15 16:32:42 UTC 2023
PRIMARY
EPA CompTox
DTXSID0022694
Created by admin on Fri Dec 15 16:32:42 UTC 2023 , Edited by admin on Fri Dec 15 16:32:42 UTC 2023
PRIMARY
NCI_THESAURUS
C65273
Created by admin on Fri Dec 15 16:32:42 UTC 2023 , Edited by admin on Fri Dec 15 16:32:42 UTC 2023
PRIMARY
WIKIPEDIA
BUCLIZINE
Created by admin on Fri Dec 15 16:32:42 UTC 2023 , Edited by admin on Fri Dec 15 16:32:42 UTC 2023
PRIMARY
CHEBI
3205
Created by admin on Fri Dec 15 16:32:42 UTC 2023 , Edited by admin on Fri Dec 15 16:32:42 UTC 2023
PRIMARY
FDA UNII
0C94V6X681
Created by admin on Fri Dec 15 16:32:42 UTC 2023 , Edited by admin on Fri Dec 15 16:32:42 UTC 2023
PRIMARY
CAS
82-95-1
Created by admin on Fri Dec 15 16:32:42 UTC 2023 , Edited by admin on Fri Dec 15 16:32:42 UTC 2023
PRIMARY
MERCK INDEX
m2744
Created by admin on Fri Dec 15 16:32:42 UTC 2023 , Edited by admin on Fri Dec 15 16:32:42 UTC 2023
PRIMARY Merck Index
DRUG CENTRAL
416
Created by admin on Fri Dec 15 16:32:42 UTC 2023 , Edited by admin on Fri Dec 15 16:32:42 UTC 2023
PRIMARY
IUPHAR
7134
Created by admin on Fri Dec 15 16:32:42 UTC 2023 , Edited by admin on Fri Dec 15 16:32:42 UTC 2023
PRIMARY
PUBCHEM
6729
Created by admin on Fri Dec 15 16:32:42 UTC 2023 , Edited by admin on Fri Dec 15 16:32:42 UTC 2023
PRIMARY
Related Record Type Details
Structure of BUCLIZINE HYDROCHLORIDE
SALT/SOLVATE -> PARENT
HISTAMINE H1 RECEPTOR
TARGET -> INHIBITOR
Structure of BUCLIZINE, (-)-
ENANTIOMER -> RACEMATE
Structure of BUCLIZINE, (+)-
ENANTIOMER -> RACEMATE
Related Record Type Details
Structure of BUCLIZINE
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966